CR
Curis, Inc.
CRIS · NASDAQ
$0.83 -7.55% (-$0.07)
1M -44.30%
Market Cap $1.62M
P/E Ratio -
Div. Yield -
ROE 1,035.26%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S 0.37x
P/B 0.34x
P/E N/A
Growth
6 /100
Declining Rev. growth 2.42%
Book val. growth 51.04%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 99.28%
FCF margin 709.02%
Net margin 490.33%
Quality
3 /100
Poor ROIC 567.17%
Asset turnover 0.23x
ROE 1,035.26%
Debt
69 /100
Low Debt/Equity 0.22x
Current ratio 0.49x
Int. coverage N/A
Stability
42 /100
Moderate Beta 3.00x
Profitable years 0
Rev. volatility 11.14%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CRIS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Dentzer
Employees
22
Headquarters
Lexington
Upcoming events
05 NOV
Earnings
Upcoming earnings report